These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22198249)

  • 1. The N-terminal extension is essential for the formation of the active dimeric structure of liver peroxisomal alanine:glyoxylate aminotransferase.
    Montioli R; Fargue S; Lewin J; Zamparelli C; Danpure CJ; Borri Voltattorni C; Cellini B
    Int J Biochem Cell Biol; 2012 Mar; 44(3):536-46. PubMed ID: 22198249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor.
    Coulter-Mackie MB; Lian Q; Wong SG
    Protein Expr Purif; 2005 May; 41(1):18-26. PubMed ID: 15802217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.
    Oppici E; Roncador A; Montioli R; Bianconi S; Cellini B
    Biochim Biophys Acta; 2013 Dec; 1832(12):2277-88. PubMed ID: 24055001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications.
    Cellini B; Bertoldi M; Montioli R; Paiardini A; Borri Voltattorni C
    Biochem J; 2007 Nov; 408(1):39-50. PubMed ID: 17696873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.
    Oppici E; Fargue S; Reid ES; Mills PB; Clayton PT; Danpure CJ; Cellini B
    Hum Mol Genet; 2015 Oct; 24(19):5500-11. PubMed ID: 26199318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant.
    Cellini B; Lorenzetto A; Montioli R; Oppici E; Voltattorni CB
    Biochimie; 2010 Dec; 92(12):1801-11. PubMed ID: 20713123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine.
    Montioli R; Oppici E; Dindo M; Roncador A; Gotte G; Cellini B; Borri Voltattorni C
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1280-9. PubMed ID: 26149463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B
    Dindo M; Oppici E; Dell'Orco D; Montone R; Cellini B
    J Inherit Metab Dis; 2018 Mar; 41(2):263-275. PubMed ID: 29110180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria.
    Pey AL; Salido E; Sanchez-Ruiz JM
    Amino Acids; 2011 Nov; 41(5):1233-45. PubMed ID: 21103899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.
    Lumb MJ; Danpure CJ
    J Biol Chem; 2000 Nov; 275(46):36415-22. PubMed ID: 10960483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1.
    Danpure CJ
    J Nephrol; 1998; 11 Suppl 1():8-12. PubMed ID: 9604801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: implications for Primary Hyperoxaluria type 1.
    Dindo M; Grottelli S; Annunziato G; Giardina G; Pieroni M; Pampalone G; Faccini A; Cutruzzolà F; Laurino P; Costantino G; Cellini B
    Biochem J; 2019 Dec; 476(24):3751-3768. PubMed ID: 31794008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the S187F variant of human liver alanine: glyoxylate [corrected] aminotransferase associated with primary hyperoxaluria type I and its functional implications.
    Oppici E; Fodor K; Paiardini A; Williams C; Voltattorni CB; Wilmanns M; Cellini B
    Proteins; 2013 Aug; 81(8):1457-65. PubMed ID: 23589421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxalate synthesis in mammals: properties and subcellular distribution of serine:pyruvate/alanine:glyoxylate aminotransferase in the liver.
    Ichiyama A; Xue HH; Oda T; Uchida C; Sugiyama T; Maeda-Nakai E; Sato K; Nagai E; Watanabe S; Takayama T
    Mol Urol; 2000; 4(4):333-40. PubMed ID: 11156700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase.
    Santana A; Salido E; Torres A; Shapiro LJ
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7277-82. PubMed ID: 12777626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.
    Fargue S; Lewin J; Rumsby G; Danpure CJ
    J Biol Chem; 2013 Jan; 288(4):2475-84. PubMed ID: 23229545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro.
    Lumb MJ; Birdsey GM; Danpure CJ
    Biochem J; 2003 Aug; 374(Pt 1):79-87. PubMed ID: 12737622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation.
    Danpure CJ; Purdue PE; Fryer P; Griffiths S; Allsop J; Lumb MJ; Guttridge KM; Jennings PR; Scheinman JI; Mauer SM
    Am J Hum Genet; 1993 Aug; 53(2):417-32. PubMed ID: 8101040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview.
    Oppici E; Montioli R; Cellini B
    Biochim Biophys Acta; 2015 Sep; 1854(9):1212-9. PubMed ID: 25620715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways.
    Danpure CJ
    Biochim Biophys Acta; 2006 Dec; 1763(12):1776-84. PubMed ID: 17027096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.